Open Access

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

  • Authors:
    • Kentaro Nakayama
    • Mohammed Tanjimur Rahman
    • Munmun Rahman
    • Kohei Nakamura
    • Masako Ishikawa
    • Hiroshi Katagiri
    • Emi Sato
    • Tomoka Ishibashi
    • Kouji Iida
    • Noriyuki Ishikawa
    • Satoru Kyo
  • View Affiliations

  • Published online on: November 26, 2015     https://doi.org/10.3892/ijo.2015.3268
  • Pages: 506-516
  • Copyright: © Nakayama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The clinicopathological significance of amplification was investigated of the gene encoding cyclin E (CCNE1) and we assessed whether CCNE1 was a potential target in endometrioid endometrial carcinomas. CCNE1 amplification and CCNE1 or F-box and WD repeat domain-containing 7 (FBXW7) expression in endometrial endometrioid carcinoma was assessed by immunohistochemistry and fluorescence in situ hybridization. CCNE1 knockdown by small interfering RNA (siRNA) was used to assess the CCNE1 function. The results showed that CCNE1 amplification was present in 9 (8.3%) of 108 endometrial carcinomas. CCNE1 amplification was correlated with high histological grade (Grade 3; p=0.0087) and lymphovascular space invasion (p=0.0258). No significant association was observed between CCNE1 amplification and FIGO stage (p=0.851), lymph node metastasis (p=0.078), body mass index (p=0.265), deep myometrial invasion (p=0.256), menopausal status (p=0.289) or patient age (p=0.0817). CCNE1 amplification was significantly correlated with shorter progression-free and overall survival (p=0.0081 and 0.0073, respectively). CCNE1 protein expression or loss of FBXW7 expression in endometrial endometrioid carcinoma tended to be correlated with shorter progression-free and overall survival; however, this difference was not statistically significant. Multivariate analysis showed that CCNE1 amplification was an independent prognostic factor for overall survival but not for progression-free survival (P=0.0454 and 0.2175, respectively). Profound growth inhibition was observed in siRNA-transfected cancer cells with endogenous CCNE1 overexpression compared with that in cancer cells having low CCNE1 expression. CCNE1 amplification was independent of p53, HER2, MLH1 and ARID1A expression but dependent on PTEN expression in endometrial carcinomas. These findings indicated that CCNE1 amplification was critical for the survival of endometrial endometrioid carcinomas. Furthermore, the effects of CCNE1 knockdown were dependent on the CCNE1 expression status, suggesting that CCNE1-targeted therapy may be beneficial for patients with endometrial endometrioid carcinoma having CCNE1 amplification.
View Figures
View References

Related Articles

Journal Cover

February 2016
Volume 48 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nakayama, K., Rahman, M.T., Rahman, M., Nakamura, K., Ishikawa, M., Katagiri, H. ... Kyo, S. (2016). CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas. International Journal of Oncology, 48, 506-516. https://doi.org/10.3892/ijo.2015.3268
MLA
Nakayama, K., Rahman, M. T., Rahman, M., Nakamura, K., Ishikawa, M., Katagiri, H., Sato, E., Ishibashi, T., Iida, K., Ishikawa, N., Kyo, S."CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas". International Journal of Oncology 48.2 (2016): 506-516.
Chicago
Nakayama, K., Rahman, M. T., Rahman, M., Nakamura, K., Ishikawa, M., Katagiri, H., Sato, E., Ishibashi, T., Iida, K., Ishikawa, N., Kyo, S."CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas". International Journal of Oncology 48, no. 2 (2016): 506-516. https://doi.org/10.3892/ijo.2015.3268